Prostate Cancer - Results from #22740

Nanotechnologies to use bisphosphonates as potent anticancer agents: The effects of zoledronic acid encapsulated into liposomes - Abstract April 22, 2011

Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy - Abstract April 22, 2011

Contemporary management of metastatic castration-resistant prostate cancer - Abstract April 22, 2011

Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer - Abstract April 22, 2011

EAU 2011 - Phase III study of intermittent MAB vs. continuous MAB - Session Highlights April 22, 2011

EAU 2011 - Risk patterns of fractures and cardiovascular and thromboembolic disease, following prostate cancer treatment: Results from the population-based PCBaSe Sweden - Session Highlights April 22, 2011

Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence - Abstract April 21, 2011

Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy - Abstract April 21, 2011

Cardiovascular risk during hormonal treatment in patients with prostate cancer - Abstract April 21, 2011

Cabazitaxel: A novel second-line treatment for metastatic castration-resistant prostate cancer - Abstract April 21, 2011

Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam) - Abstract April 21, 2011

Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer - Abstract April 21, 2011

Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: Correlation with multi-parametric MRI - Abstract April 21, 2011

Impact of nocturia on disease-specific quality of life for men with localized prostate cancer - Abstract April 21, 2011

Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial - Abstract April 21, 2011

Provenge: Revolutionary technology or ethical bust? - Abstract April 21, 2011

Androgen deprivation therapy in prostate cancer: Are rising concerns leading to falling use? - Abstract April 21, 2011

Editor's Commentary - Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement April 21, 2011

EAU 2011 - Prostate cancer screening: Can it be improved with total testosterone levels? - Session Highlights April 21, 2011

EAU 2011 - Prostate cancer incidence and disease-specific survival in men participating in the ERSPC with an initial PSA under 3.0 ng/ml - Session Highlights April 21, 2011

Page 1138 of 1164